Surgical Mesh - Medical Devices Pipeline Assessment: Post-Operative Complications Trigger Refurbishments

Published on : Feb 15, 2019

Albany, New York, February 15, 2019: Surged prevalence of urogynecological ailments encompassing organ prolapse and urinary incontinence in women have augmented adoption of surgical mesh. However, post-operative complications such as infections, erosion, and organ wear and tear have remained potential challenges. Leading pharmaceutical entities are thus akin on diverting substantial investments towards product innovations pertaining surgical mesh medical device pipeline development to address unmet clinical needs. In its recent research offering titled, 'Surgical Mesh - Medical Devices Pipeline Assessment, 2019', Market Research Hub (MRH) delves deep to gauge recent developments and evaluates their reciprocal implications on holistic growth route of surgical mesh pipeline.

Tela Bio Inc. and Aroa Biosurgery Jointly Launch OviTex as the Next Gen Surgical Mesh for Soft Tissue Repair

In their bid to cater larger unmet needs on the back of growing patient pools, device companies are keen on entering into long term contracts and strategic coalitions to attain groundbreaking breakthroughs in the development of advanced surgical mesh, thereby enriching their surgical mesh medical devices pipeline.

Several clinical trials and research endeavors are at different stages of development, thus stakeholders and device companies are also targeting ample resources towards FDA approvals and subsequent commercialization of refurbished portfolio.

In a recent development, Tela Bio collaboration with Aroa Biosurgery have recently affirmed FDA clearance for their surgical mesh, OviTex intended for soft tissue repair. Following this, the companies have also commercially launched OviTex, thus enticing substantial growth in surgical mesh medical device space.

Unbiased research postulates articulated in the report aim to offer report readers with palpable information on current market developments in terms of micro and macroeconomic factors as well as dynamics such as drivers, restraints, threats, and challenges that impact surgical mesh pipeline. The report assesses the surgical mesh medical devices pipeline landscape on the basis of coherent segments such as stage of development, territory, regulatory path, and estimated approval date. The executive summary section tagged in the report allow readers to decipher critical understanding about these market developments on the basis of which established as well as aspiring entrants in surgical mesh medical devices space can effectively employ winning strategies to attain consolidation amidst stiffening competition. 

Competition Deep-Dive: Surgical Mesh Medical Devices Pipeline Assessment

Thorough research elements encompassed in the trailing sections of the report allow readers to identify potential forerunners in surgical mesh medical devices pipeline realm. Each of the profiled companies has been meticulously evaluated and assessed and an intricate SWOT analysis has also been entailed to allow readers decipher substantial efficacy of tactical business strategies employed by leading companies in luring favorable market growth and favorable consumer response. Some of the leading companies identified in surgical mesh medical devices market include, Tela Bio, Anika Therapeutics Inc Company, and Fibralign Corporation amongst others.

Request a Sample with TOC in a PDF format :

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top